IL13RA2 and myeloid sarcoma: Given that T cell responses directed against MAGE and IL-13Rα2 antigens also involve T cells with low affinity to these self-antigens, we quantified antigen-specific responses based on cytokine secretion, as recently described in a phase I study of patients with MS [41].